Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Voyageur Pharmaceuticals Ltd announced it raised $316,000 in an initial filing from an offering of $4.76 Million

PRIVATEAug 10, 2026•about 2 hours ago

Amount Raised

$316,000

Round Type

Seed

CalgaryManufacturingBiotechnologyPharmaceutical

Company Information

Company

Voyageur Pharmaceuticals

Location

Calgary, Alberta, Canada

About

Voyageur Pharmaceuticals Ltd. is a Canadian public company trading under the symbol VM on the TSXV, focusing on developing barium and iodine Active Pharmaceutical Ingredients (API) and offering high-performance, cost-effective imaging contrast agents. The company has a strategic focus on vertically integrating the barium and iodine contrast market.

Related People

Suggested for you
1 contact
Verified contactsNo contacts on file at Voyageur Pharmaceuticals yet.
Predictive Intelligence
Strategic

ML-powered predictions for Voyageur Pharmaceuticals's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.